In contrast, in this study, the concentrations of FFA in plasma and liver tissue were significantly decreased in the NAFLD models after activation of β3-AR by BRL37344 for 4 weeks (Fig. 3f and Table 2). Here, ADRB3 is linked to metabolic dysfunction-associated steatotic liver disease.